NLRP3 and triple-negative breast carcinoma: The findings indicated that miRNA-1290 might impair the radiosensitivity of triple-negative breast cancer cells by inhibiting NLRP3-mediated pyroptosis, which might be regarded as a novel therapeutic option (Li and Li 2022).